AMSbiopharma, our specialized line of analytical solutions for the quality control of pharmaceutical products, announces the launch of a service for the analysis of nitrosamines in vitamin B12. This service, developed with state-of-the-art technology, makes a difference in the analytical services for…
The R&D&I projects NANOFLUITEDEC and Digital BIOCoV develop a functional prototype for the detection of SARS-Cov-2 virus RNA and an early detection system for anticovid activity from natural products
This morning, the event to present the results of the R&D&I projects NANOFLUIDETEC and DIGITAL BIOCoV, within the framework of the CONECTA COVID 2021 programme, as part of the European Union’s response to the COVID-19 pandemic, was held in the…
New facilities with the highest standards of quality, comfort and energy efficiency
In the AMSlab Group, we continue to be immersed in a series of changes that are taking place in accordance with the growth and evolution that we are experiencing. One of these changes consists of the acquisition of an industrial…
A Galician consortium comprising AMSlab, AMSbiopharma, BFLOW and USC investigates PCR-based SARS-COV-2 detection systems
The project called Rapid and automatable detection for SARS-Cov-2 based on PCR, nanotechnology and microfluidics (NANOFLUIDETEC) is investigating the development of a detection system for SARS-CoV-2, the virus that causes the disease COVID-19, based on molecular techniques and integrating nanotechnology…



